The Fintiv decision, made in March 2020, led to a significant decrease in the number of times inter partes review (IPR) cases were rejected, falling from 40-50% to 11-16%. In June 2022, Director Vidal issued a memo saying that the PTAB would not use the Fintiv criteria to reject a case if there was an ongoing court action and the petition had strong evidence that the patent was not valid. However, in February 2023, Director Vidal clarified that PTAB panels must first analyze the Fintiv criteria before looking at the case’s merits. This led to a lot of confusion among the public. In under two months, with concerns rising about a potential rise in Fintiv denial rates, the USPTO announced the ANPRM.Â
The USPTO wants to ensure that their rules match the goals of encouraging innovation and investment, as well as the intentions of the AIA law, which is to provide a cost-effective alternative to district court litigation to address some patentability concerns while also safeguarding against patentee harassment. Before the USPTO forms possible regulations in a Notice of Proposed Rulemaking (NPRM), the ANPRM allows the public to submit initial feedback on suggestions from both the USPTO and the public. Â
The USPTO evaluated the effect of any such rule on the economy, the integrity of the patent system, the efficient administration of the USPTO, and the capacity of the USPTO to conclude proceedings commenced under 35 U.S.C. 316(b) in a timely manner in the ideas contained in the ANPRM.Â
The USPTO is seeking feedback on a variety of proposals concerning the rules that the Director, and by delegation, the PTAB, will utilize in exercising discretion to institute inter partes reviews and post-grant reviews under 35 U.S.C. 314(a), 324(a), and 325(d). The USPTO is also asking for feedback on ideas that would allow petitioners to pay extra fees for petition word count limits, establish a separate briefing process for discretionary institution arguments, and ensure that parties who settle prior to institution must file copies of any settlement agreements with the PTAB.Â
This ANPRM provides a chance for inventors, investors, and stakeholders to submit comments on the intended changes that the USPTO will make, as well as any changes that the USPTO will not move forward with.Â